Skip to main content
. 2017 Dec 29;4(4):153–158. doi: 10.1016/j.ijpam.2017.12.002

Table 4.

Empiric therapy for pediatric community-acquired pneumonia (CAP) – inpatient.

Site of Care (Inpatient). Empiric Therapy for Presumed Bacterial Pneumonia
Empiric Therapy for Presumed Atypical Pneumonia
Empiric Therapy for Presumed Influenza Pneumonia
Antibiotic Route Regimen Antibiotic Route Regimen Antiviral
Uncomplicated CAP. Initial therapy Ampicillin IV 200 mg/kg/day divided every 6 hr. Azithromycin IV/PO Given as a single daily dose; 10 mg/kg on day 1; 5 mg/kg on days 2 to ss 5 Oseltamivir
Or Penicillin G IV 250,000-400,000 U/kg/day divided every 4–6h
Alternative *Amoxicillin clavulanate IV 90 mg/kg/day divided every 8 hr. Clarithromycin PO 15 mg/kg/day in 2 doses for 7–14 days.
Or *Cefuroxime IV 150 mg/kg/day divided every 8 hr. Or Erythromycin IV/PO 40mg/kg/day in 4 doses
Complicated CAP. Ceftriaxone IV 75mg/kg/day every 24 hr. Same Empiric Therapy for Presumed Atypical Pneumonia in Uncomplicated Pneumonia.
**Clindamycin IV 40mg/kg/day divided every q8h
Or**Vancomycin IV 60mg/kg/day divided every q8h

Doses was adapted from 2017 Nelson's Pediatric Antimicrobial Therapy, 23rd Ed.

*Consider in children whom not completing Haemophilus influenzae type b (Hib) vaccines series (three doses).

** Consider if infection suspected due to community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) especially in cases of Necrotizing pneumonia, Sepsis, Concurrent skin infection due to MRSA, and/or Previous MRSA colonization. IV Intravenously; PO Orally.